Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Cancers|April 3, 2021
Epigenetic Biomarkers for the Diagnosis and Treatment of Liver DiseaseMaría Arechederra, Miriam Recalde, María Gárate-Rascón, et al.International Journal of Molecular Sciences|November 11, 2022
SLU7: A New Hub of Gene Expression Regulation-From Epigenetics to Protein Stability in Health and DiseaseMaría Gárate-Rascón, Miriam Recalde, Carla Rojo, et al.Cells|September 15, 2020
Deletion or Inhibition of NOD1 Favors Plaque Stability and Attenuates Atherothrombosis in Advanced Atherogenesis †Silvia González-Ramos, Victoria Fernández-García, Miriam Recalde, et al.Nucleic Acids Research|July 31, 2021
The splicing regulator SLU7 is required to preserve DNMT1 protein stability and DNA methylationMiriam Recalde, María Gárate-Rascón, María Elizalde, et al.Cancers|May 14, 2022
DNA Methylation Regulates a Set of Long Non-Coding RNAs Compromising Hepatic Identity during HepatocarcinogenesisMiriam Recalde, María Gárate-Rascón, José María Herranz, et al.Journal of Physiology and Biochemistry|September 21, 2024
Comprehensive in silico CpG methylation analysis in hepatocellular carcinoma identifies tissue- and tumor-type specific marks disconnected from gene expressionIdoia Bilbao, Miriam Recalde, Fabrice Daian, et al.JHEP Reports : Innovation in Hepatology|August 6, 2024
Caspases compromise SLU7 and UPF1 stability and NMD activity during hepatocarcinogenesisCarla Rojo, María Gárate-Rascón, Miriam Recalde, et al.Hepatology (Baltimore, Md.)|June 25, 2021
Splicing Factor SLU7 Prevents Oxidative Stress-Mediated Hepatocyte Nuclear Factor 4α Degradation, Preserving Hepatic Differentiation and Protecting From Liver DamageMaría Gárate-Rascón, Miriam Recalde, Maddalen Jimenez, et al.Gut|April 25, 2020
Epigenetic mechanisms and metabolic reprogramming in fibrogenesis: dual targeting of G9a and DNMT1 for the inhibition of liver fibrosisMarina Barcena-Varela, Hannah Paish, Laura Alvarez, et al.Pageof 1